$0.77
2.39% today
Nasdaq, May 21, 08:50 pm CET
ISIN
KYG7S53R1049
Symbol
PROK
Sector
Industry

Prokidney Target price 2025 - Analyst rating & recommendation

Prokidney Classifications & Recommendation:

Buy
40%
Hold
60%

Prokidney Price Target

Target Price $4.50
Price $0.79
Potential
Number of Estimates 4
4 Analysts have issued a price target Prokidney 2026 . The average Prokidney target price is $4.50. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 5 analysts: 2 Analysts recommend Prokidney to buy, 3 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Prokidney stock has an average upside potential 2026 of . Most analysts recommend the Prokidney stock at Hold.

Sales and Margin forecast 2025, 2026 to 2029

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '24 2025
Estimates
Revenue Million $ 0.08 0.09
15.00%
EBITDA Margin -216,150.00% -196,931.18%
9.47%
Net Margin -226,842.50% -70,306.00%
29.97%

5 Analysts have issued a sales forecast Prokidney 2025 . The average Prokidney sales estimate is

$92.0k
Unlock
. This is
70.32% lower
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$230k 25.81%
Unlock
, the lowest is
$0.0 100.00%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2024 $80.0k
2025
$92.0k 15.00%
Unlock
2026
$0.0 100.00%
Unlock

4 Analysts have issued an Prokidney EBITDA forecast 2025. The average Prokidney EBITDA estimate is

$-181m
Unlock
. This is
3.66% lower
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
$-151m 15.89%
Unlock
, the lowest is
$-215m 19.87%
Unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2024 $-173m 17.10%
2025
$-181m 4.11%
Unlock
2026
$-187m 3.44%
Unlock
2027
$-193m 3.05%
Unlock

EBITDA Margin

2024 -216,150.00%
2025
-196,931.18% 9.47%
Unlock

2 Prokidney Analysts have issued a net profit forecast 2025. The average Prokidney net profit estimate is

$-64.7m
Unlock
. This is
16.78% higher
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$-58.1m 62.53%
Unlock
, the lowest is
$-71.3m 54.07%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2024 $-181m 8.77%
2025
$-64.7m 19.47%
Unlock
2026
$-62.0m 4.19%
Unlock
2027
$-107m 72.02%
Unlock

Net Margin

2024 -226,842.50%
2025
-70,306.00% 29.97%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2029

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '24 2025
Estimates
Earnings Per Share $ -0.62 -0.50
8.77% 19.35%
P/E negative
EV/Sales 12,458.37

2 Analysts have issued a Prokidney forecast for earnings per share. The average Prokidney EPS is

$-0.50
Unlock
. This is
16.67% higher
Unlock
than earnings per share in the financial year 2024. The highest EPS forecast is
$-0.45 15.09%
Unlock
, the lowest is
$-0.55 3.77%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2024 $-0.62 8.77%
2025
$-0.50 19.35%
Unlock
2026
$-0.48 4.00%
Unlock
2027
$-0.82 70.83%
Unlock

P/E ratio

Current -1.32 81.43%
2025
-1.59 20.45%
Unlock
2026
-1.66 4.40%
Unlock
2027
-0.96 42.17%
Unlock

Based on analysts' sales estimates for 2025, the Prokidney stock is valued at an EV/Sales of

12,458.37
Unlock
and an P/S ratio of
1,117.07
Unlock
.

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 3,697.32
2025
12,458.37 236.96%
Unlock

P/S ratio

Current
2025
1,117.07 236.96%
Unlock

Current Prokidney Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
JP Morgan
Locked
Locked
Locked Sep 30 2024
Guggenheim
Locked
Locked
Locked Sep 10 2024
B of A Securities
Locked
Locked
Locked Sep 04 2024
Analyst Rating Date
Locked
JP Morgan:
Locked
Locked
Sep 30 2024
Locked
Guggenheim:
Locked
Locked
Sep 10 2024
Locked
B of A Securities:
Locked
Locked
Sep 04 2024

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today